Octalfa
Family officeLyon · Pre-Seed–Late Stage
Find your way into Octalfa
Investment thesis
Octalfa is a family holding company operating in three complementary ways: seed financing, company creation, and buyouts. It invests from a company's first financing round with the ability to follow on in later rounds, typically committing between EUR 150k and EUR 400k, with a goal of making 10 investments in France. It also supports entrepreneurs-in-residence to build new ventures, co-creating and financing companies with EUR 100k to EUR 2M depending on maturity. Additionally, it finances management buyouts of profitable B2B (non-service) companies with enterprise values between EUR 1M and EUR 5M, becoming the reference shareholder able to fund the next development cycle.
Source: firm website, verified Aug 7, 2026.
What they invest in
from 4 of 6 portfolio companiesBiotech ×3Medical Devices ×3Healthtech ×2AI & Machine Learning ×1Deep Tech ×1Impact & Social Good ×1Longevity ×1
HQs:France×4
Investments · 6 tracked
founders shown can be your intro path
Kimialys provides antibody selection and kinetic characterization services using proprietary Surface Plasmon Resonance imaging (SPRi) technology and K-One surface chemistry for researchers and diagnostics developers.
AI & Machine LearningBiotechDeep TechMedical Devices
Co-investorsAngels SantéSuper Capital VC
Sirius NeoSight develops a patented technology that measures cell membrane fluidity using a fluorescent molecule to detect, isolate and characterise Circulating Tumour Cells (CTCs) from blood samples.
BiotechHealthtechMedical DevicesLyon, FR
Arnaud Vigneron(Co-founder)inDavid Gueyrard(Co-founder)inJean-Guillaume Lafay(Co-founder)Stéphane Legastelois(Co-founder)in
Co-investorsAngels Santé
Ventuno is a biotech company developing cancer therapies that leverage the immune system to target and eliminate cancer cells in difficult-to-treat tumors.
BiotechHealthtechLongevityMedical DevicesLyon, FR
Co-investorsBpifrance
Corporate foundation of the Alberici family that funds and supports charitable projects run by associations and NGOs to improve the quality of life of people with disabilities and cancer patients.
Impact & Social Good
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Orega BiotechOrphelia Pharma
Frequently asked questions
- How many investments has Octalfa made?
- Octalfa has 6 tracked investments.
- What stage does Octalfa invest at?
- Octalfa invests at the Pre-Seed, Seed, Series A, Late Stage stages.
- What is Octalfa's typical check size?
- Octalfa typically writes checks of $100K – $2.7M.
- What sectors does Octalfa focus on?
- Octalfa focuses on Biotech, Deep Tech, New Materials.
- Where is Octalfa located?
- Octalfa is headquartered in Lyon, FR.
- Does Octalfa lead rounds?
- Yes, Octalfa leads investment rounds.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Giant Ventures is a venture capital firm investing in technology that transforms civilization's foundational systems across sectors including AI, energy, materials, industry, work, finance, biology and healthcare.
Blindspot Ventures is an infrastructure-focused technology investment fund that backs founders building foundational platforms, systems, and technologies for critical industries.
Fundamental Ventures is an early-stage venture firm that backs founders removing fundamental constraints holding back human progress, spanning hard tech, deep science, and network/workflow innovations.
Deep Insight is an Israel-focused venture capital fund investing in deep tech companies across all sectors and stages, describing itself as the first dedicated Israeli fund for all deep tech opportunities.